Herzrhythmusstörungen bei alten Menschen — Möglichkeiten und Grenzen der Therapie

  • A. A. Schöneberger
Conference paper

Zusammenfassung

Die Erkennung und Behandlung von Herzrhythmusstörungen bei älteren Patienten stellt ein wichtiges klinisches Problem dar, das heute nicht nur den kardiologisch tätigen Arzt konfrontiert. Kardiovaskuläre Erkrankungen sind vorwiegend Erkrankungen des älteren Menschen geworden, wobei sich über 70% der kardiovaskulär bedingten Todesfälle im Alter nach 65 Jahren ereignen. Dabei scheinen Arrhythmien häufiger denn je im Alter vorzukommen. Dafür könnte die verbesserte Erfassungsmöglichkeit, z. B. mittels Langzeit EKG-Registrierung, verantwortlich sein. Aber auch die im Alter weit verbreitete Anwendung von herz- und kreislaufwirksamen Medikamenten, wie Digitalis und Diuretika, scheint durch ihre Wirkung auf den Herzrhythmus eine Rolle zu spielen. Ein weiterer wichtiger Grund liegt in der Zunahme der allgemeinen Lebenserwartung, da z.B. die Häufigkeit ventrikulärer Extrasystolen mit dem Alter selbst bei Herzgesunden ansteigt (Tabelle 1). Gleichzeitig erscheinen auf dem Arzneimittelmarkt laufend neue Antiarrhythmika (Tabelle 2). Diese Medikamente sind keineswegs frei von Nebenwirkungen, die vor allem beim älteren Patienten durch eine veränderte Pharmakokinetik gehäuft vorkommen können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anderson KP, De Camilla J, Moss AJ (1978) Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation S 7Google Scholar
  2. 2.
    Andresen D, von Leitner ER, Wegschneider K, Schröder R (1984) Standardisierter psychischer Belastungstest zur Provokation tachykarder ventrikulärer Rhythmusstörungen. Vergleich mit Langzeit-EKG und Belastungs-EKG. Dtsch med Wochenschr 109: 532–536PubMedCrossRefGoogle Scholar
  3. 3.
    Armstrong WF, McHenry PL (1985) Ambulatory electrocardiographic monitoring: can we predict sudden death? J Am Coll Cardiol 5:13 BCrossRefGoogle Scholar
  4. 4.
    Bastian BC, McFarland PW, McLauchlan JH, Ballantyne D, Clark R, Hillis WS, Rae AP, Hutton I (1980) A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J 100:1017PubMedCrossRefGoogle Scholar
  5. 5.
    Bernovitz NL ( 1974) Clinical applications of the pharmakokinetics of lidocainc. Cardiovasc Clin 6:77Google Scholar
  6. 6.
    Bethge, KP (1982) Langzeit-Elektrokardiographie. Springer Berlin Heidelberg New YorkGoogle Scholar
  7. 7.
    Bethge KP, Bethge HC, Graf A, van den Berg E, Lichtlen P (1977) Kammer-Arrhythmien bei chronisch koronarer Herzkrankheit. Z Kardiol 66:1PubMedGoogle Scholar
  8. 8.
    Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM and The Multicenter Post-Infarction Research Group (1984) The relationship among ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69: 250PubMedCrossRefGoogle Scholar
  9. 9.
    Bigger JT, Weld FM, Rolnitzky LM (1981) Prevalence, characteristics and significance of ventricular tachycardia detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. Am J Cardiol 48: 815PubMedCrossRefGoogle Scholar
  10. 10.
    Breithardt G, Borggrefe M (1985) Heutige Möglichkeiten der Therapie maligner ventrikulärer Herzrhythmusstörungen bei koronarer Herzkrankheit. Dtsch med Wochenschr 110:1983PubMedCrossRefGoogle Scholar
  11. 11.
    Burckhardt D, Luetold BE, Jost MV, Hoffmann A (1982) Holter monitoring in the evaluation of palpitations, dizziness and syncope. In: Roelandt J, Hugenholtz PG (eds) Long-term ambulatory electro-cardiography. Martin Nijhoff Publ, The Hague S 29CrossRefGoogle Scholar
  12. 12.
    Calvert A, Lown B, Gorlin R (1977) Ventricular premature beats and anatomically defined coronary heart disease. Am J Cardiol 39: 627PubMedCrossRefGoogle Scholar
  13. 13.
    Camm AJ, Evans KE, Ward DE, Martin A (1980) The rhythm of the heart in active elderly subjects. Am Heart J 99: 598PubMedCrossRefGoogle Scholar
  14. 14.
    Chamberlain DA, Jewitt DE, Julian DG, Campbell RWF, Boyle D (1980) Oral mexiletine in high-risk patients after myocardial infarction. Lancet 2:1324PubMedCrossRefGoogle Scholar
  15. 15.
    Curtius JM, Loogen F (1985) Therapie des Miltralklappenprolaps und seiner Komplikationen. Dtsch med Wochenschr 110: 595PubMedCrossRefGoogle Scholar
  16. 16.
    Dancy M, Camm AJ, Ward D (1985) Misdiagnosis of chronic recurrent ventricular tachycardia. Lancet 2:320PubMedCrossRefGoogle Scholar
  17. 17.
    Dietz A, Walter J, Bracharz H, Bracharz M, Unkelbach S, Franke H (1987) Herzrhythmusstörungen bei rüstigen älteren Personen. Altersabhängigkeit von Herzfrequenz und Arrhythmien. Z Kardiol 76: 86PubMedGoogle Scholar
  18. 18.
    European Infarction Study Group (1985) Decreasing prognostic significance of complex ventricular tachyarrhythmias in the late postinfarction period. Circulation 72 (Suppl III): 359Google Scholar
  19. 19.
    Fleg JL, Kennedy HL (1982) Cardiac arrhythmias in a healthy elderly population. Detection by 24-hour ambulatory electrocardiography. Chest 81: 302PubMedCrossRefGoogle Scholar
  20. 20.
    Fox TT, Weaver J, March HW (1952) On the mechanism of the arrhythmias in the aberrant atrioven-tricular conduction (Wolff-Parkinson-White). Am Heart J 43: 507PubMedCrossRefGoogle Scholar
  21. 21.
    Forfar JC, Miller HC, Toft AD (1979) Occult thyrotoxicosis: a correctable cause of „idiopathic“ atrial fibrillation. Am J Cardiol 44: 9PubMedCrossRefGoogle Scholar
  22. 22.
    Furlanello F, Macca F, Palu CD (1972) Observation on a case of Jervell and Lange-Nielsen syndrome in an adult. Br Heart J 34: 648PubMedCrossRefGoogle Scholar
  23. 23.
    Fuster V, Gersch BJ, Giuliani FR, Tajik AJ, Brandenburg RD, Frye RL (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47: 525PubMedCrossRefGoogle Scholar
  24. 24.
    Gajewski J, Singer RB (1981) Mortality in an insured population with atrial fibrillation. JAMA 245: 1540PubMedCrossRefGoogle Scholar
  25. 25.
    Gibson TC, Heitzman MR (1984) Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol 53:1013PubMedCrossRefGoogle Scholar
  26. 26.
    Glasser SP, Clark PI, Applebaum HJ (1979) Occurrence of frequent complex arrhythmias detected by ambulatory monitoring. Findings in an apparently healthy asymptomatic elderly population. Chest 75: 565PubMedCrossRefGoogle Scholar
  27. 27.
    Goodwin JF, Oakley CM (1972) The cardiomyopathies. Br Heart J 34: 545PubMedCrossRefGoogle Scholar
  28. 28.
    Gottlieb SH, Achuff SL, Mellits ED, Gerstenblith G, Baughman KL, Becker L, Chandra NC, Henley S, Humphries J O’N, Heck C, Kennedy MH, Weisfeldt ML, Reid PR (1987) Prophylactic antiarrhythmic therapy of high risk survivors of myocardial infarction: Lower mortality at 1 month but not at 1 year. Circulation 75: 792PubMedCrossRefGoogle Scholar
  29. 29.
    Graboys TB, Lown B, Podrid PJ, De Silva RA (1982) Long-term survival of patients with ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 50: 437PubMedCrossRefGoogle Scholar
  30. 30.
    Grundersen T, Abrahamsen AM, Kjekshus J, Ronnevik PK (1982) Timolol-related reduction in mortality and reinfarction in patients ages 65-77 years surviving acute myocardial infarction. Circulation 66: 1179CrossRefGoogle Scholar
  31. 31.
    Hagemejer F, Herwejer Á (1979) Antiarrhythmic therapy after myocardial infarction. Heart Bull 10:184Google Scholar
  32. 32.
    Hess OM, Turina J, Goebel NH (1977). Zur Prognose der kongestiven Kardiomyopathie. Z Kardiol 66: 351PubMedGoogle Scholar
  33. 33.
    Hillis WS, Whiting B (1983) Antiarrhythmic drags. Br Med J 286: 1332CrossRefGoogle Scholar
  34. 34.
    Horowitz LN, Josephson ME, Kastor JA (1980) Intracardiac electrophysiologic studies as method for the optimization of drug therapy in chronic ventricular arrhythmia. Prog Cardiovasc Dis 23: 81PubMedCrossRefGoogle Scholar
  35. 35.
    Hurwitz N (1969) Predisposing factors in adverse reactions to drugs. Br Med J 1: 536PubMedCrossRefGoogle Scholar
  36. 36.
    Hyatt RH, Sinha B, Vallon A, Bailey RJ, Martin A (1988) Noncardiac side-effects of long-term oral amiodarone in the elderly. Age Ageing 17:116PubMedCrossRefGoogle Scholar
  37. 37.
    Ikegawa T, Chino M, Hasegawa H, Usuba F, Suzuk S, Ookura M, Nishikawa K (1987) Prognostic significance of 24-hour ambulatory elektrocardiographic monitoring in patients with dilative cardio-myopathy: a prospective study. Clin Cardiol 10: 78PubMedCrossRefGoogle Scholar
  38. 38.
    Jervell A, Lange-Nielsen F (1957) Congenital deafmutism, functional heart disease, with prolanga-tion of the QT interval and sudden death. Am Heart J 54: 59PubMedCrossRefGoogle Scholar
  39. 39.
    Jeresaty RM (1976) Sudden death in the mitral valve prolapse click syndrome. Am J Cardiol 37: 316CrossRefGoogle Scholar
  40. 40.
    Jeresaty RM (1985) Mitral valve prolapse an update. JAMA 254: 793PubMedCrossRefGoogle Scholar
  41. 41.
    Johnson AM (1971) Aortic stenosis, sudden death, and the left ventricular baroreceptors. Brit Heart J 33:lCrossRefGoogle Scholar
  42. 42.
    Kafka W(1985) Prävalenz, therapeutische Beeinflussung und prognostische Bedeutung ventrikulärer Arrhythmien beim Mitralklappenprolapssyndrom. Z Kardiol 74: 245Google Scholar
  43. 43.
    Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation. The Framingham study. N Engl J Med 306:1018PubMedCrossRefGoogle Scholar
  44. 44.
    Kannel WB, Schatzkin A (1985) Sudden death: Lessons from subsets in population studies. J Am Coll Cardiol 5:141 BCrossRefGoogle Scholar
  45. 45.
    Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ (1985) Long-term follow up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 312:193PubMedCrossRefGoogle Scholar
  46. 46.
    Klein GJ, Bashore TM, Sellers TD, Pritchett LC, Smith WM, Gallagher JJ (1979) Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301: 1080PubMedCrossRefGoogle Scholar
  47. 47.
    Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 317: 669PubMedCrossRefGoogle Scholar
  48. 48.
    Kumpke CW, Bean WB (1948) A study of clinical and pathological aspect of 107 cases of proven aortic stenosis. Medicine (Baltimore) 27:139Google Scholar
  49. 49.
    von Leitner ER, Andresen D (1987) Diagnostische Bedeutung des Langzeit-EKG nach Myokardin-farkt. Internist 28: 143Google Scholar
  50. 50.
    Levin RM (1987) Thyrotoxicosis in the elderly. J Am Geriatr Soc 35: 587–589PubMedGoogle Scholar
  51. 51.
    Levine BJ, Zeldis SM, Morganroth J, Kastor JA (1978) Lack of correlation between symptoms and significant arrhythmias on long term electrocardiographic analysis. Clin Res 26: 247 AGoogle Scholar
  52. 52.
    Lie KJ, Wellens HJ, van Capelle FJ, Durrer D (1974) Lidocaine in the prevention of primary ventricular fibrillation. A double-blind randomized study of 212 consecutive patients. N Engl J Med 291:132CrossRefGoogle Scholar
  53. 53.
    Lowenstein ST, Gabow PA, Cramer J, Oliva PB, Ratner K (1983) The role of alcohol in new-onset atrial fibrillation. Arch Intern Med 143:1882PubMedCrossRefGoogle Scholar
  54. 54.
    Lown B, De Silva RA (1978) Roles of psychologic stress and autonomic nervous changes in provocation of ventricular premature complexes. Am J Cardiol 41: 979PubMedCrossRefGoogle Scholar
  55. 55.
    Lown B, Wolf M (1971) Approaches to sudden death. Circulation 44:130PubMedGoogle Scholar
  56. 56.
    Marcus FI, Ruskin JN, Surawicz B (1987) III Characteristics of specific cardiovascular disorders in the elderly. Arrhythmias. J Am Coll Cardiol 10: 66 ACrossRefGoogle Scholar
  57. 57.
    Margolis B, De Silva RA, Lown B (1980) Episodic drug treatment in the management of paroxysmal arrhythmias. Am J Cardiol 45: 621PubMedCrossRefGoogle Scholar
  58. 58.
    Maron BJ, Savage DD, Wolfson JK, Epstein SE (1981)The prognostic significance of 24 h ambulatory electrocardiographic monitoring in patients with hypertrophie cardiomyopathy a prospective study. Am J Cardiol 48:252PubMedCrossRefGoogle Scholar
  59. 59.
    Mathewson FAL, Varan GS (1960) Abnormal electrocardiograms in the apparently healthy people. Circulation 21: 196PubMedGoogle Scholar
  60. 60.
    McKenna WJ, England D, Doi YL, Deaiifield JB, Oakley C, Goodwin JF (1981) Arrhythmia in hypertrophic cardiomyopathy. I Influence on prognosis. Br Heart J 46:168PubMedCrossRefGoogle Scholar
  61. 61.
    Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop TV, Leitner FR, Andresen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53:902PubMedCrossRefGoogle Scholar
  62. 62.
    Mitchell JH, Shapiro W (1969) Atrial function and the hemodynamic sequences of atrial fibrillation in man. Am J Cardiol 23: 556PubMedCrossRefGoogle Scholar
  63. 63.
    Morady F, Baerman JM, Di Carlo LA jr, DeBuitleir M, Krol RB, Wehr DW (1985) A prevalent misconception regarding wide-complex tachycardias. JAMA 254: 2790PubMedCrossRefGoogle Scholar
  64. 64.
    Mukharji J, Rude RE, Poole WK, Gustafson N, Thomas CJ, Strauss HW, Jaffe AS, Muller JE, Roberts R, Raabe jr DS, Croft C, Passamani E, Braunwald E, Willerson JT and the Milis study group (1984) Risk factors for sudden death after acute myocardial infarction two year follow-up. Am J Cardiol 54:31PubMedCrossRefGoogle Scholar
  65. 65.
    Multicenter Postinfarction Research Group (1983) Risk stratification and survival after myocardial infarction. N Engl J Med 309: 331CrossRefGoogle Scholar
  66. 66.
    The multicenter dialtiazem postinfarction trial research group (1988) The effect of dialtiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319: 385CrossRefGoogle Scholar
  67. 67.
    Ochs HR, Greenblatt DJ, Woo E, Smith TW (1978) Reduced quinidine clearance in elderly persons. Am J Cardiol 42:481PubMedCrossRefGoogle Scholar
  68. 68.
    Platia EV, Blinker JA (1987) Tachyarrhythmias and pacemaker therapy. In: Management of cardiac arrhythmias. The nonpharmaologic approach. Platia EV(ed) JP Lippincott Company, Philadelphia S: 201Google Scholar
  69. 69.
    Platia EV, Watkins L jr, Mower MM, Griffith LSC, Reid PR, Mirowski M (1987). In: Management of cardiac arrhythmias. The nonpharmacologic approach. Platia EV (ed) JB Lipincott Company, Philadelphia S: 272Google Scholar
  70. 70.
    Podrid PJ, Schöneberger A, Lown B (1980) Congestive heart failure caused by oral disopyramide. N Engl J Med 302:613CrossRefGoogle Scholar
  71. 71.
    Pollak H, Arnoldor O, Diez W, Prachar H, Enenkel W (1988) Der akute Myokardinfarkt bei über 70jährigen. Dtsch med Wschr 113: 203PubMedCrossRefGoogle Scholar
  72. 72.
    Reidenberger MM, Camacho M, Kluger J, Drayer DE (1980) Aging and renal clearance of procainamide and acetylprocainamide. Clin Pharmacol Ther 28: 732CrossRefGoogle Scholar
  73. 73.
    Rich EC, Siebold C, Campion B (1985) Alcohol-related acute atrial fibrillation: a case control study and review of 40 patients. Arch Int Med 145: 803CrossRefGoogle Scholar
  74. 74.
    Rodstein M, Wolloch L, Gubner RS (1971) Mortality study of the significance of extrasystoles in an insured population. Circulation 44: 617PubMedGoogle Scholar
  75. 75.
    Samet P (1973) Hemodynamic sequelae of cardiac arrhythmias. Circulation 47: 399PubMedGoogle Scholar
  76. 76.
    Schaffer WA, Cobb LA (1975) Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl J Med 293: 259PubMedCrossRefGoogle Scholar
  77. 77.
    Schöneberger A, Bamberg E, Bussmann WD (1981) QT-Syndrom ohne QT-Verlängerung. Klin Wschr 59: 281CrossRefGoogle Scholar
  78. 78.
    Schöneberger A, Podrid PJ, Lown B (1985) Incidence of congestive heart failure from antiarrhythmic drugs. Cardiovascular Pharmacotherapy, International Symposium 1985, Geneva, abstr: 305Google Scholar
  79. 79.
    Schultze RA, Strauss HW, Pitt B (1977) Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospital phase and left ventricular ejection fraction. Am J Med 62:192CrossRefGoogle Scholar
  80. 80.
    Schwartz LS, Goldfischer J, Sprahue GJ, Schwartz SP (1971) Syncope and sudden death in aortic stenosis. Am J Cardiol 23: 647CrossRefGoogle Scholar
  81. 81.
    Schwartz PJ, Periti M, Malliani A (1975) The Long QT Syndrome. Am Heart J 89: 378PubMedCrossRefGoogle Scholar
  82. 82.
    Selzer A (1982) Atrial fibrillation revisited. N Engl J 306:1044CrossRefGoogle Scholar
  83. 83.
    Swerdlow CD, Winkle RA, Mason JW (1983) Determinants of survival in patients with ventricular arrhythmias. N Engl J Med 308:1436PubMedCrossRefGoogle Scholar
  84. 84.
    Steinbeck G, Manz M, Lüderitz B (1981) Möglichkeiten und Risiken der programmierten Ventrikelstimulation bei Patienten mit chronisch rezidivierenden Kammertachykardien. Klin Wochenschr 59: 111PubMedCrossRefGoogle Scholar
  85. 85.
    Stewart RB, Bardy GH, Greene HL (1986) Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med 104: 766PubMedGoogle Scholar
  86. 86.
    Vaughan Williams EM (1970) Classification ot antiarrhythmic drugs In: Sandoe E, Flensted-Jensen E, Olsen KH (eds) Cardiac arrhythmias Astra SödertälgeGoogle Scholar
  87. 87.
    Velebit V, Podrid PJ, Lown B, Cohen BH, Graboys TB (1982) Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65: 886PubMedCrossRefGoogle Scholar
  88. 88.
    Wei JY, Bulkley BH, Schaeffer H, Greene HL, Reid PR (1978) Mitral valve prolapse syndrome and recurrent ventricular arrhythmias. Ann Intern Med 54: 59Google Scholar
  89. 89.
    Wellens HJJ (1978) Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias. Circulation 57: 845PubMedGoogle Scholar
  90. 90.
    Wellens HJJ (1986) The wide QRS tachycardia. Ann Intern Med 104: 879PubMedGoogle Scholar
  91. 91.
    Werdan K (1987) Bedeutung von Herzrhythmusstörungen beim Mitralklappenprolaps-Syndrom. Internist 28:175PubMedGoogle Scholar
  92. 92.
    Wiese VH, Walter J, Schramm A, Gärtner FR, Bracharz M (1981) Art und Häufigkeit von Herzrhythmusstörungen in Abhängigkeit vom Patientenalter, therapeutische Aspekte. Z Kardiol 70: 516PubMedGoogle Scholar
  93. 93.
    Wolf PA, Dawber TR, Thomas HE jr, Kännel WB (1978) Epidermiologic assessment of chronic atrial fibrillation and risk of stroke. The Framingham Study. Neurology 28: 973Google Scholar
  94. 94.
    Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction. An overview of the randomized trials. Prog Cardiovasc Dis 27: 335PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1990

Authors and Affiliations

  • A. A. Schöneberger
    • 1
  1. 1.Klinik der Krankenversorgung der Bundesbahn-Beamten (KVB)für Herz- und GefäßkrankheitenKonigstein/TaunusDeutschland

Personalised recommendations